Jack O'Brien is a journalist who specializes in healthcare and pharmaceutical industry news. He writes for publications such as MM+M and The Clinical Advisor, and his work has also been featured in PRWeek. Jack covers topics ranging from FDA approvals and industry trends to healthcare crises and advancements in medical treatments.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Jack O Brien's coverage predominantly revolves around healthcare and pharmaceuticals. He is particularly interested in press releases, private sector announcements, and data citations related to the pharmaceutical industry. Therefore, he would likely be more responsive to pitches offering exclusive access to new research findings or insights into developments within this industry.
Given his focus on press releases and private sector announcements, Jack may appreciate being approached by individuals with intimate knowledge of the inner workings of the pharmaceutical industry or those who can provide unique perspectives on healthcare trends and marketing strategies.
While no specific geographic focus was mentioned for Jack's reporting, it is clear that his primary interest lies in covering topics related to the global healthcare and pharmaceutical sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
This is a return to form for Dupixent, which was one of the top Rx and OTC pharma brands in 2023 but was outperformed by the likes of Vicks and Rinvoq in early 2024.
The docuseries will be reformatted as an hour-long documentary airing nationally on PBS in July.
See which leaders are on the move across the pharma, biotech and medical marketing industries.
Takeda said that while it will offer more specifics related to timing and actions for the restructuring at a later date, it expects to incur a one-time expense of $900 million for fiscal year 2024.
By: Darryn King, Jack O Brien, George C. Wolfe
The director Jack O’Brien and the writer, director and producer George C. Wolfe will each receive the 2024 Special Tony Award for Lifetime Achievement in the Theatre.
Check out this week's medical marketing news, dealmaking and industry chatter. May 10, 2024 7:12 am Deals:
Sanofi is entering into a co-exclusive licensing agreement with Novavax in an effort to combat COVID-19 and the flu.
The nation's ongoing drug shortages have forced leaders on Capitol Hill to act. May 10, 2024 12:29 pm
CTV’s share of impressions among pharma advertisers has grown 36% since 2019.
The Hampton Jitney campaign follows in the footsteps of some of other New York metro area transportation marketing efforts undertaken by Ro, including subway station takeovers promoting GLP-1 drugs.
(833) 317-6278 
